期刊文献+

脂质纳米粒提高尿酸氧化酶体外稳定性的初步研究 被引量:7

Preliminary study on the stability of urate oxidase loaded in lipid nanoparticles
下载PDF
导出
摘要 目的:使用Tricine-Na OH缓冲液制备含UOX的脂质纳米粒(urate oxidase lipid nanoparticles prepared by Tricine-Na OH buffer,UTLNs),并对游离尿酸氧化酶(urate oxidase,UDX)在体外的活性和稳定性进行初步研究。方法:采用逆向蒸发法制备UTLNs。分别从最适温度、最适p H、热稳定性、贮存稳定性、酸碱稳定性和抗胰蛋白酶水解能力初步考察游离UOX和UTLNs的差异。结果:游离UOX和UTLNs最适温度均为40℃;游离UOX最适p H为8.5,UTLNs最适p H为8.0;稳定性结果显示,UTLNs的体外稳定性明显优于游离UOX。结论:UTLNs不仅提高了UOX在体外的活性,并且明显地增强了UOX在体外的稳定性。 Objective :To prepare urate oxidase lipid nanoparticles by Tricine-NaOH buffer(UTLNs) and then to study the in vitro ac- tivity and stability of free UOX and UTLNs. Methods : UTLNs was prepared by reverse-phase evaporation method. The optimum tem- perature, optimum pH,thermal stability, storage stability, pH stabilities and proteolytic stabilities of free UOX and UTLNs were mea- sured. Results :The optimum temperatures for free UOX and UTLNs were both 40 ℃. The optimum pH for free UOX and UTLNs were 8.5 and 8.0,respectively. UTLNs had significantly better stability than free UOX in vitro. Conclusion:UTLNs not only improved the activity but also significantly enhanced the stability of free UOX in vitro.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2014年第10期1452-1456,共5页 Journal of Chongqing Medical University
基金 国家自然科学基金资助项目(编号:30973645) 重庆市首批高等学校优秀人才资助项目(编号:【渝教人(2009)2号】)
关键词 尿酸酶 脂质纳米粒 最适温度 最适PH 稳定性 urate oxidase lipid nanoparticles optimum temperature optimum pH stability
  • 相关文献

参考文献13

  • 1寇文娥,荣俊,于勤.猪尿酸酶动力学特性研究[J].中国医药生物技术,2009,4(2):128-133. 被引量:6
  • 2Sherman MR,Saifer MG,Perez-Ruiz F.PEG-uricase in the manage- ment of treatment-resistant gout and hyperuricemia[J].Adv Drug Deliv Rev, 2008,60( 1 ) : 59-65.
  • 3Pasut G,Sergi M,Veronese FM.Anti-cancer PEG-enzymes:30 years old, but still a current approach[J].Adv Drug Deliv Rev, 2008,60( 1 ) : 69-78.
  • 4Tan QY,Wang N,Yang H,et al.Characterization,stabilization and activity of uricase loaded in lipid vesicles[J].Int J Pharm,2010,384( 1- 2) : 165-172.
  • 5Huang SH,Wu TK.Modified colorimetric assay for uricase activity and a screen for mutant Bacillus subtilis uficase genes following StEP mutagensis[J].Eur J Biochem, 2004,271 (3) : 517-523.
  • 6Patte C,Sakiroglu O,Sommelet D.European experience in the treat- ment of hyperuricemia[J].Semin Hematol, 2001,38 ( 4 S 10 ) : 9-12.
  • 7Pui CH.Urate oxidase in the prophylaxis or treatment of hyper- uricemia: the United States experience[J].Semin Hematol, 2001,38 (g S10) : 13-21.
  • 8Goldman SC,Holcenberg JS,Finklestein JZ,et al.A randomized comparison between rasbuficase and allopurinol in children with lym- phoma or leukemia at high risk for tumor lysis[J].Blood,2001,97(10): 2998-3003.
  • 9Cui Y,Wu Z, Liu X, et al.Preparation,safety,pharmacokinetics, and pharmacodynamics of liposomes containing Brucea javanica oiI[J].AAPS PharmSciTech, 2010,11 (2) : 878-884.
  • 10E1-Gahami MA,Albishfi HM.Equilibrium studies of dibutyltin (IV) -zwitterionic buffer complexation.J Solution Chem, 2013, (42) :2012-2024.

二级参考文献5

  • 1钱文雨,赵兴秀,田素华,刘震,童仕波,姚庆,陈莉莉,许墨松,王东,孟延发.产朊假丝酵母(Candida utilis)尿酸酶的基本特性[J].兰州大学学报(自然科学版),2006,42(6):62-64. 被引量:2
  • 2Lei Kai,Xiao-Hang Ma,Xue-Lai Zhou,Xiao-Ming Jia,Xia Li,Kang-Ping Guo. Purification and characterization of a thermostable uricase from Microbacterium sp. strain ZZJ4-1[J] 2008,World Journal of Microbiology and Biotechnology(3):401~406
  • 3Salih Pay MD,Robert Terkeltaub MD. The case for uricase in gout[J] 2003,Current Rheumatology Reports(3):213~214
  • 4P. Montalbini,J. Redondo,J. L. Caballero,J. Cárdenas,M. Pineda. Uricase from leaves: its purification and characterization from three different higher plants[J] 1997,Planta(3):277~283
  • 5Liu Jianguo,Li Gaoxiang,Liu Hong,Zhou Xiukai. Purification and properties of uricase fromCandida sp. and its application in uric acid analysis in serum[J] 1994,Applied Biochemistry and Biotechnology(1):57~63

共引文献5

同被引文献44

  • 1吴晓英,吴振强,林影,夏枫耿.L-天冬酰胺酶的研究进展[J].广东药学,2003,13(6):42-44. 被引量:5
  • 2霍红光,方波,江体乾.聚乙二醇改性壳聚糖固定化L-天门冬酰胺酶的工艺研究[J].华东理工大学学报(自然科学版),2005,31(1):13-17. 被引量:4
  • 3钱国强,周菊岩,马建标,王道宾,何炳林.壳聚糖微球固定化L-天门冬酰胺酶研究[J].高等学校化学学报,1996,17(7):1147-1150. 被引量:40
  • 4施特尔马赫 钱嘉渊(译).酶的测定方法[M].北京:中国轻工业出版社,1992.186-194.
  • 5林爱华,刘奕明,平其能.甘草酸表面修饰阿霉素壳聚糖纳米粒的制备及特性研究[J].中国药科大学学报,2007,38(6):507-511. 被引量:11
  • 6van den Berg H. Asparaginase revisited [J]. LeukLymphoma, 2011, 52 (2) : 168-178.
  • 7Narta UK, Kanwar SS, Azmi W. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia [J], Crit Rev Oncol Hematol, 2007, 61 (3): 208-221,.
  • 8Mohan-Kumari HP, Dhale MA, Akhilender Naidu K, et al. Antioxidant effect of red mould rice in hypercholesterolemic Wistar male rats [J]. Cell Biochem Funct, 2011, 29 (7) : 597-602.
  • 9Ha W, Meng XW, Li Q, et al. Self-assembly hollow nano- sphere for enzyme encapsulation[J]. Soft Matter, 2010, 6: 1405-1408.
  • 10Li Q, Xia B, Branham M, et al. Self-assembly of carboxy- methyl konjac glucomannan-g-poly (ethylene glycol) and (ct-cyclodextrin) to biocompatible hollow nanospheres for glucose oxidase encapsulation [J]. Carbohyd Polym, 2011, 86(1): 120-126.

引证文献7

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部